Sharekhan

Indegene Ltd

Fri 2/05/2025,10:24:56 | NSE : INDGN

₹ 542.10-5.65 (-1.03%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 556.00

Previous Close

₹ 547.75

Volume

76026

Mkt Cap ( Rs. Cr)

₹13010.83

High

₹ 556.00

Low

₹ 535.10

52 Week High

₹ 736.30

52 Week Low

₹ 470.10

Book Value Per Share

₹ 98.34

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Indegene Ltd

Your Vote -

Buy

75.00%

Hold

0.00%

Sell

25.00%

75.00%

4 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

47%

Sell Order Quantity

53%

Bid Price

Qty

538.60

5

539.00

10

538.00

46

538.00

108

538.00

100

Bid Total

34904

Bid Price

Qty

538.95

33

539.00

415

539.00

12

539.00

21

539.00

10

Bid Total

39479

Option Chain

Analyzes market sentiment, predicts Indegene Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Indegene - Copy of Newspaper Publication

    30 Apr 2025, 12:47PM Indegene Limited has informed the Exchange about Copy of Newspaper Publication.
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    29 Apr 2025, 7:45PM Audio Recording of the Q4FY25 earnings call
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    29 Apr 2025, 7:44PM Indegene Limited has informed the Exchange about Link of Recording
  • Indegene - Monitoring Agency Report

    28 Apr 2025, 8:39PM Monitoring Agency Report for the quarter ended March 31, 2025
  • Indegene - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    28 Apr 2025, 8:39PM Monitoring Agency Report for the quarter ended March 31, 2025
  • Indegene - Investor Presentation

    28 Apr 2025, 8:35PM Indegene Limited has informed the Exchange about Investor Presentation
  • Indegene - Alteration Of Capital and Fund Raising-XBRL

    28 Apr 2025, 8:35PM INDEGENE LIMITED has informed the Exchange regarding Allotment of Securities
  • Indegene - Press Release

    28 Apr 2025, 8:31PM Indegene Limited has informed the Exchange regarding a press release dated April 28, 2025, titled ""Press Release - Financial results for the quarter
  • Indegene - Announcement under Regulation 30 (LODR)-Investor Presentation

    28 Apr 2025, 8:25PM Analyst presentation and Fact sheet - Financial results for the quarter and financial year ended March 31, 2025.
  • Indegene Q4 net profit up 10.84% at Rs 54.20 cr

    28 Apr 2025, 8:20PM The company reported standalone net profit of Rs 54.20 crore for the quarter ended March 31, 2025 as compared to Rs 48.90 crore in the same period las
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    28 Apr 2025, 8:14PM Press Release - Financial Results for the quarter and financial year ended March 31, 2025.
  • Indegene - Outcome of Board Meeting-XBRL

    28 Apr 2025, 7:58PM INDEGENE LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 28-Apr-2025 for Dividend
  • Indegene - Announcement under Regulation 30 (LODR)-Dividend Updates

    28 Apr 2025, 7:58PM Intimation of Outcome of Board Meeting- Recommendation of Final Dividend.\r\n\r\n
  • Indegene - Outcome of Board Meeting

    28 Apr 2025, 7:57PM Indegene Limited has informed the Exchange regarding Outcome of Board Meeting held on April 28, 2025.
  • Indegene - Dividend

    28 Apr 2025, 7:50PM Indegene Limited has informed the Exchange that Board of Directors at its meeting held on April 28, 2025, recommended Final Dividend of Rs. 2 per equi
  • Indegene - Board Meeting Outcome for Intimation Of Outcome Of Board Meeting

    28 Apr 2025, 7:48PM Intimation of Outcome of Board Meeting
  • Indegene - Dividend

    28 Apr 2025, 7:45PM Indegene Limited has informed the Exchange that Board of Directors at its meeting held on April 28, 2025, recommended Final Dividend of 2 per equity s
  • Indegene - Updates

    24 Apr 2025, 5:09PM Indegene Limited has informed the Exchange regarding 'Change in contact details of MUFG Intime India Private Limited, Registrar and Transfer Agent of
  • Indegene - Change In Contact Details Of MUFG Intime India Private Limited, Registrar And Transfer Agent Of The Company.

    24 Apr 2025, 5:09PM Change in Contact details of MUFG Intime India Private Limited, Registrar and Transfer Agent of the Company
  • Indegene - Alteration Of Capital and Fund Raising-XBRL

    21 Apr 2025, 6:01PM INDEGENE LIMITED has informed the Exchange regarding Allotment of Securities
  • Indegene has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    21 Apr 2025, 6:00PM As of March 2025, 100.00% owned by Public. <p align=justify> Institutional holds 10.20% (Insurance Companies 0.04%) and Non-Institutional holds 89.80%
  • Indegene - Allotment of Securities

    21 Apr 2025, 5:58PM Indegene Limited has informed the Exchange regarding allotment of 47462 securities pursuant to ESOP/ESPS at its meeting held on April 21, 2025
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    21 Apr 2025, 5:10PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Board Meeting Intimation

    21 Apr 2025, 4:59PM INDEGENE LIMITED has informed the Exchange about Board Meeting to be held on 28-Apr-2025 to consider and approve the Yearly Audited Financial results
  • Indegene - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    21 Apr 2025, 5:59PM Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    21 Apr 2025, 5:16PM Intimation of Indegene Q4FY25 Earnings Call
  • Indegene - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And

    21 Apr 2025, 4:58PM Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2025 ,inter alia, to consider and approve
  • Indegene - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    18 Apr 2025, 7:10PM Voting Results along with Scrutinizer's Report on Postal Ballot.
  • Indegene - Shareholders meeting

    18 Apr 2025, 7:05PM Indegene Limited has submitted the Exchange a copy Srutinizers report along with voting results of Postal Ballot
  • Indegene - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    15 Apr 2025, 3:13PM Indegene Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Indegene - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Apr 2025, 3:15PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants)Regulations, 2018 for the quarter ended March 31, 2025.
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Mar 2025, 11:06PM Indegene Limited has informed the Exchange about Intimation of Cancellation of investor Calls
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 Mar 2025, 9:17PM Cancellation of scheduled Analyst / Investor Meeting on 31st March 2025
  • Indegene - Trading Window-XBRL

    27 Mar 2025, 1:04PM Indegene Limited has informed the Exchange about Closure of Trading Window
  • Indegene - Trading Window

    27 Mar 2025, 12:50PM Indegene Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Indegene - Announcement under Regulation 30 (LODR)-Investor Presentation

    26 Mar 2025, 7:06PM Investor Presentation
  • Indegene - Investor Presentation

    26 Mar 2025, 7:05PM Indegene Limited has informed the Exchange about Investor Presentation
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 Mar 2025, 6:10PM Intimation of Schedule of Analyst / Investor Meeting
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    26 Mar 2025, 6:10PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - General Updates

    26 Mar 2025, 3:05PM Indegene Limited has informed the Exchange about General Updates
  • Indegene - Corrective Action On NSE Letter

    26 Mar 2025, 3:07PM Corrective Action on NSE Letter
  • Indegene - Acquisition-XBRL

    25 Mar 2025, 6:15PM INDEGENE LIMITED has informed the Exchange regarding Acquisition
  • Indegene - Announcement under Regulation 30 (LODR)-Acquisition

    25 Mar 2025, 6:11PM Disclosure under Regulation 30 of SEBI(LODR)Regulations,2015
  • Indegene - Acquisition

    25 Mar 2025, 6:11PM Indegene Limited has informed the Exchange about Acquisition
  • Indegene - Acquisition-XBRL

    20 Mar 2025, 4:47PM INDEGENE LIMITED has informed the Exchange regarding Acquisition
  • Indegene - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    20 Mar 2025, 4:46PM INDEGENE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Indegene - Updates

    19 Mar 2025, 10:41PM Indegene Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Reg
  • Indegene - Change in Auditors

    19 Mar 2025, 10:36PM Indegene Limited has informed the Exchange regarding Change in Auditors of the company.
  • Indegene - Press Release

    19 Mar 2025, 4:11PM Indegene Limited has informed the Exchange regarding a press release dated March 19, 2025, titled ""ndegene Expands Presence in Europe, Announces New
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 Mar 2025, 4:16PM Press Release - Indegene Expands Presence in Europe, Announces New Center in London
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Mar 2025, 7:56PM Intimation of Schedule of Analyst/Investor Meeting
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Mar 2025, 7:56PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Press Release

    18 Mar 2025, 3:39PM Indegene Limited has informed the Exchange regarding a press release dated March 18, 2025, titled "" Financial Times Names Indegene Among High-Growth
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    18 Mar 2025, 3:39PM Press Release-Financial Times Names Indegene Among High -Growth Companies in Asia-Pacific 2025.
  • Indegene - Copy of Newspaper Publication

    18 Mar 2025, 2:45PM Indegene Limited has informed the Exchange about Copy of Newspaper Publication - Postal Ballot.
  • Indegene - Notice Of Shareholders Meetings-XBRL

    17 Mar 2025, 12:40PM INDEGENE LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot
  • Indegene - Shareholders meeting

    17 Mar 2025, 12:13PM Indegene Limited has informed the Exchange regarding Notice of Postal Ballot.
  • Indegene - Alteration Of Capital and Fund Raising-XBRL

    14 Mar 2025, 5:03PM INDEGENE LIMITED has informed the Exchange regarding Allotment of Securities
  • Indegene - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    14 Mar 2025, 5:01PM INDEGENE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Indegene - General Updates

    13 Mar 2025, 8:02PM Indegene Limited has informed the Exchange about outcome of circular resolution regarding reappointment of Independent Directors subject to shareholde
  • Indegene - Intimation Of Outcome Of Resolution Passed By Circulation

    13 Mar 2025, 7:57PM Reappointment of Independent Directors subject to shareholder approval and allotment of shares under the RSU plan 2020
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Mar 2025, 5:20PM Indegene Limited has informed the Exchange about Intimation for hosting `Investor Day .
  • Indegene - Press Release

    10 Mar 2025, 10:59AM Indegene Limited has informed the Exchange regarding a press release dated March 10, 2025, titled ""Press Release - Deloitte Names Indegene a Winner o
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    10 Mar 2025, 5:28PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the Stock Exchanges that the
  • Deloitte names Indegene a Winner of Enterprise Growth Awards 2025

    10 Mar 2025, 12:03PM Indegene, a digital-first life sciences commercialization company, has been honored as one of the standout winners of Deloitte Private&rsquo;s Enterpr
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    10 Mar 2025, 10:58AM Pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015, enclosed herewith is a press release dated March 10, 2025, titled \r\n'Deloitte Names Indeg
  • Indegene - Updates

    6 Mar 2025, 7:37PM Indegene Limited has informed the Exchange regarding 'Change in website address of investor relation page.'.
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Mar 2025, 5:10PM Indegene Limited has informed the Exchange about Schedule of meet of Analyst / Investor(s) Meeting(s).
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Mar 2025, 5:15PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, we would like to inform you that the Officials o
  • Indegene - Alteration Of Capital and Fund Raising-XBRL

    24 Feb 2025, 3:51PM INDEGENE LIMITED has informed the Exchange regarding Allotment of Securities
  • Indegene - Updates

    24 Feb 2025, 11:32AM Indegene Limited has informed the Exchange regarding 'Intimation of outcome of resolution passed by Circulation under Regulation 30 of the SEBI (Listi
  • Indegene - Press Release

    24 Feb 2025, 10:50AM Indegene Limited has informed the Exchange regarding a press release dated February 24, 2025, titled "" Indegene Launches Cortex, A Fit-For-Purpose Ge
  • Indegene - Intimation Of Outcome Of Resolution Passed By Circulation Under Regulation 30 Of The SEBI (Listing Obligations And

    24 Feb 2025, 11:40AM Allotment of shares under RSU Plan 2020 and ESOP Plan 2020
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    24 Feb 2025, 10:51AM Pursuant to Regulation 30 of the SEBI LODR Regulations, 2015, enclosed herewith is a press release dated February 24, 2025, titled 'Indegene Launches
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Feb 2025, 3:52PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Feb 2025, 3:47PM Indegene Limited has informed the Exchange about Schedule of meet.
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 Feb 2025, 3:54PM Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 Feb 2025, 3:50PM Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the
  • Indegene - General Updates

    18 Feb 2025, 3:45PM Indegene Limited has informed the Exchange about resolution proposed to be passed by Circulation under Regulation 30 of the SEBI (Listing Obligations
  • Indegene - Intimation Of Resolution Proposed To Be Passed By Circulation.

    18 Feb 2025, 3:46PM Pursuant to Regulation 30 of the SEBILODR Regulations, 2015, we hereby inform you that the following resolutions of Board of Directors of Indegene Lim
  • Indegene - Intimation Regarding The Change Of Name Of Registrar And Transfer Agent ('RTA') From 'Link Intime India Private Li

    13 Feb 2025, 8:09PM This is to inform you that the company has received an email communication from its RTA on February 13, 2025, the RTA name has been changed from \LINK
  • Indegene - Updates

    13 Feb 2025, 8:01PM Indegene Limited has informed the Exchange regarding 'Intimation regarding the change of name of Registrar and Transfer Agent ( RTA ) from Link Intim
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Feb 2025, 7:35PM Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Feb 2025, 7:31PM \r\nPursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Feb 2025, 7:30PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Feb 2025, 7:28PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Feb 2025, 7:27PM Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Feb 2025, 7:25PM Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Feb 2025, 7:25PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Feb 2025, 7:22PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    13 Feb 2025, 7:12PM Pursuant to Regulation 326 of SEBI LODR Regulations, 2015 read with Regulation 414 of SEBI ICDR Regulations, 2018, Please find attached Monitoring Age
  • Indegene - Monitoring Agency Report

    13 Feb 2025, 7:01PM Intimation of Monitoring Agency Report for the quarter ended December 31, 2024 .
  • Indegene - Integrated Filing (Financial)

    13 Feb 2025, 6:37PM Revised Integrated Filing Financial for the quarter ended 31st December 2024.
  • Indegene - Integrated Filing- Financial

    13 Feb 2025, 6:09PM Integrated Filing (Financial) for the quarter ended on December 31, 2024 .
  • Indegene - Statement of deviation(s) or variation(s) under Reg. 32

    13 Feb 2025, 5:17PM Indegene Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  • Indegene - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds For The Quarter Ended December 31, 2024

    13 Feb 2025, 5:25PM Pursuant to Reg 32 of SEBILODR Regulations, 2015, we hereby attach statement of Deviation/Variation in utilization of funds raised through Public Issu
  • Indegene - Press Release

    11 Feb 2025, 5:29PM Indegene Limited has informed the Exchange regarding a press release dated February 11, 2025, titled "" Everest Group Recognizes Indegene as a Front-R
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    11 Feb 2025, 5:35PM Pursuant to Reg 30 of SEBILODR Regulations, 2015, enclosed herewith is a press release dated February 11, 2015, titled 'Everest Group Recognizes Indeg
  • Indegene - Integrated Filing- Financial

    10 Feb 2025, 5:37PM Integrated Filings - Financial Q3FY25
  • Indegene - Integrated Filing (Financial)

    10 Feb 2025, 5:58PM Integrated Filing (financial) for the quarter ended 31st December 2024
  • Indegene - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    6 Feb 2025, 3:20PM Pursuant to Regulation 30 of the SEBILODR, Regulation, 2015, please find enclosed the transcript of the conference call for the quarter ended December
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Feb 2025, 3:20PM Indegene Limited has informed the Exchange about Transcript of the conference call.
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    6 Feb 2025, 12:04PM Pursuant to Reg 30 of SEBILODR Regulation, 2015, enclosed herewith is a press release dated FEB 06, 2025, titled 'Indegene Expands Footprint in Europe
  • Indegene - Press Release

    6 Feb 2025, 12:01PM Indegene Limited has informed the Exchange regarding a press release dated February 06, 2025, titled "" Indegene Expands Footprint in Europe, Launches
  • Indegene

    20 Mar 2025 , 11:34AM The company launched a new centre In London to expand in Europe. This aligns with the company's long-term growth strategy in Europe, reiterating its commitment to enable life sciences clients in the region to be future-ready.
  • Indegene

    3 Dec 2024 , 11:16AM Global private equity firm Carlyle-backed CA Dawn Investments likely to divest 2.9% stake in Indegene via block deal at Rs.615 per share. As per media sources, the sale could raise approximately Rs 470 crore, based on the offered floor price.
  • Indegene announces strategic collaboration with Microsoft

    11 Jul 2024 , 11:38AM Indegene collaborates with Microsoft to help life sciences companies scale up Generative AI adoption

Key fundamentals

Evaluate the intrinsic value of Indegene Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1888.2 953.8 795.3 650 442.2
Liabilities 1888.2 953.8 795.3 650 442.2
Equity 47.9 44.4 44.3 0.4 0.3
Gross Profit 180.5 168 177.9 168.7 150.4
Net Profit 181.3 137.9 130.2 132.7 133.4
Cash From Operating Activities 129 176.2 81.9 38.2 54.6
NPM(%) 16.57 13.18 12.94 15.85 26.1
Revenue 1093.6 1045.6 1005.7 836.7 511
Expenses 913.1 877.6 827.8 668 360.6
ROE(%) 7.68 5.84 5.51 5.62 5.65

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
2 100 0 571.5

Peers

Other companies within the same industry or sector that are comparable to Indegene Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Visagar Polytex Ltd 0.86 1.18 0.00 16047.33 -53.07 0.00
India Motor Parts and Accessories Ltd 998.95 0.54 15.89 684.22 592.31 2.70
Madhya Pradesh Today Media Ltd 31.70 0.00 5.44 250.44 55.30 0.00
Hathway Cable and Datacom Ltd 13.61 0.81 26.17 97045.73 26.13 0.00

Company Info

Our Company was incorporated as `Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a private limited company, under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 16, 1998, issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli at Ahmedabad. Thereafter, the registered office of our Company was shifted from Gujarat to Karnataka in June 2003, and then, from Karnataka to Maharashtra in May 2014. Further, pursuant to a resolution passed by our Shareholders at the EGM held on February 29, 2016, the name of our Company was changed to `Indegene Private Limited' and a fresh certificate of incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. The name of our Company was changed to better reflect the nature of business undertaken by our Company. Thereafter, the registered office of our Company was shifted from Maharashtra to Karnataka in February 2017. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on November 7, 2022 and the name of our Company was changed to `Indegene Limited' and a fresh certificate of incorporation was issued to our Company by the RoC, on November 17, 2022.Major events and milestones:2005-Raised funding from Nadathur Holdings & Investments Private Limited-Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.-Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore2006-Acquisition of Medsn, Inc.1 a company in the USA which is engaged in medical education and marketing business, by one of our Material Subsidiaries, Indegene, Inc.2 through the merger of Medsn Merger Sub, Inc., an erstwhile wholly owned subsidiary of Indegene, Inc. with Medsn, Inc.2007-Expanded our services to include European territory2008-Received BS ISO/IEC 27001:2005 certification for information security management system32009-Received ISO 9001:2000 certification for quality management system42012-Expanded operations to China by incorporating a subsidiary named Indegene Lifesystems Consulting (Shanghai) Co., Ltd.2017-Acquisition of the Encima Group, Inc., a corporation which operates a digital service, marketing automation and analytics services business supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.2020-Acquisition of DT Associates Research and Consulting Services Limited, a consulting services company in UK supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.-Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences2021-Expanded operations to Japan by incorporating a subsidiary named Indegene Japan, LLC-Raised equity funding from CA Dawn Investments and Brighton Park Capital-Received BS ISO/IEC 27701:2019 certification for privacy information management system52022-Acquisition of Medical Marketing Economics, LLC by one of our Material Subsidiaries, ILSL Holdings, Inc. and subsequent merger of Medical Marketing Economics, LLC with Indegene, Inc.-Expanded global operations with new offices in Mexico2023-Acquisition of Cult Health, a company engaged in the business of providing advertising services to parties in the healthcare sector, by one of our Material Subsidiaries, ILSL Holdings, Inc.-Expanded our presence in Europe with the acquisition of Indegene Healthcare Germany GmbH (formerly Sotus 852 GmbH) by our subsidiary, Indegene Ireland Limited-Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform2024-Acquisition of Trilogy Writing & Consulting GmbH, a company engaged in providing high-end medical writing to customers that include market-leading pharmaceutical companies, along with three of its wholly owned subsidiaries, by one of our Subsidiaries, Indegene Ireland Limited.-Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India

Our Company was incorporated as `Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a private limited company, under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 16, 1998, issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli at Ahmedabad. Thereafter, the registered office of our Company was shifted from Gujarat to Karnataka in June 2003, and then, from Karnataka to Maharashtra in May 2014. Further, pursuant to a resolution passed by our Shareholders at the EGM held on February 29, 2016, the name of our Company was changed to `Indegene Private Limited' and a fresh certificate of incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. The name of our Company was changed to better reflect the nature of business undertaken by our Company. Thereafter, the registered office of our Company was shifted from Maharashtra to Karnataka in February 2017. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on November 7, 2022 and the name of our Company was changed to `Indegene Limited' and a fresh certificate of incorporation was issued to our Company by the RoC, on November 17, 2022.Major events and milestones:2005-Raised funding from Nadathur Holdings & Investments Private Limited-Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.-Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore2006-Acquisition of Medsn, Inc.1 a company in the USA which is engaged in medical education and marketing business, by one of our Material Subsidiaries, Indegene, Inc.2 through the merger of Medsn Merger Sub, Inc., an erstwhile wholly owned subsidiary of Indegene, Inc. with Medsn, Inc.2007-Expanded our services to include European territory2008-Received BS ISO/IEC 27001:2005 certification for information security management system32009-Received ISO 9001:2000 certification for quality management system42012-Expanded operations to China by incorporating a subsidiary named Indegene Lifesystems Consulting (Shanghai) Co., Ltd.2017-Acquisition of the Encima Group, Inc., a corporation which operates a digital service, marketing automation and analytics services business supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.2020-Acquisition of DT Associates Research and Consulting Services Limited, a consulting services company in UK supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.-Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences2021-Expanded operations to Japan by incorporating a subsidiary named Indegene Japan, LLC-Raised equity funding from CA Dawn Investments and Brighton Park Capital-Received BS ISO/IEC 27701:2019 certification for privacy information management system52022-Acquisition of Medical Marketing Economics, LLC by one of our Material Subsidiaries, ILSL Holdings, Inc. and subsequent merger of Medical Marketing Economics, LLC with Indegene, Inc.-Expanded global operations with new offices in Mexico2023-Acquisition of Cult Health, a company engaged in the business of providing advertising services to parties in the healthcare sector, by one of our Material Subsidiaries, ILSL Holdings, Inc.-Expanded our presence in Europe with the acquisition of Indegene Healthcare Germany GmbH (formerly Sotus 852 GmbH) by our subsidiary, Indegene Ireland Limited-Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform2024-Acquisition of Trilogy Writing & Consulting GmbH, a company engaged in providing high-end medical writing to customers that include market-leading pharmaceutical companies, along with three of its wholly owned subsidiaries, by one of our Subsidiaries, Indegene Ireland Limited.-Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India

Read More

Parent Organisation

Indegene Ltd.

Founded

16/10/1998

Managing Director

Mr.Manish Gupta

NSE Symbol

INDGNEQ

FAQ

The current price of Indegene Ltd is ₹ 542.10.

The 52-week high for Indegene Ltd is ₹ 556.00 and the 52-week low is ₹ 535.10.

The market capitalization of Indegene Ltd is currently ₹ 13010.83. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Indegene Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Indegene Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Indegene Ltd shares.

The CEO of Indegene Ltd is Mr.Manish Gupta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT